![Leaf Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 69 $ as of 30/09/2026
Leaf Huang is the founder of Lipella Pharmaceuticals, Inc. which was founded in 2005.
He held the title of Director from 2005 to 2013.
Dr. Huang is also the founder of LipoGenics, Inc., RGene Therapeutics, Inc., OncoTrap, Inc. Dr. Huang earned a doctorate degree from Michigan State University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2025 | 69,443 ( 1.5% ) | 69 $ | 30/09/2026 |
| Companies | Position | Start |
|---|---|---|
LipoGenics, Inc.
 LipoGenics, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dietary supplements | Founder | 19/02/2010 |
RGene Therapeutics, Inc.
 RGene Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Research and design of gene therapy | Founder | 19/02/2010 |
| Companies | Position | End |
|---|---|---|
OncoTrap, Inc.
 OncoTrap, Inc. Miscellaneous Commercial ServicesCommercial Services Develops the medicine that induces or potentiates the immune response as a means to eradicate tumor burden | Founder | - |
| LIPELLA PHARMACEUTICALS INC. | Founder | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Lipella Pharmaceuticals, Inc.
 Lipella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes lipid-based therapies for common bladder syndromes | Health Technology |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LipoGenics, Inc.
LipoGenics, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dietary supplements | Consumer Non-Durables |
RGene Therapeutics, Inc.
RGene Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Research and design of gene therapy | Commercial Services |
OncoTrap, Inc.
OncoTrap, Inc. Miscellaneous Commercial ServicesCommercial Services Develops the medicine that induces or potentiates the immune response as a means to eradicate tumor burden | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions
